BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27092832)

  • 1. Interpretation of Clinical Trials That Stopped Early.
    Viele K; McGlothlin A; Broglio K
    JAMA; 2016 Apr; 315(15):1646-7. PubMed ID: 27092832
    [No Abstract]   [Full Text] [Related]  

  • 2. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to interpret a randomized controlled study stopped early.
    Leandro G
    Intensive Care Med; 2013 Sep; 39(9):1642-3. PubMed ID: 23797787
    [No Abstract]   [Full Text] [Related]  

  • 8. Early Termination of Randomized Clinical Trials in Orthopaedics.
    Piuzzi N; Chughtai M; Khlopas A; Gwam CU; Muschler G; Spindler KP; Mont MA
    Surg Technol Int; 2017 Feb; 30():290-294. PubMed ID: 28182822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pocock approach to sequential meta-analysis of clinical trials.
    Shuster JJ; Neu J
    Res Synth Methods; 2013 Sep; 4(3):269-79. PubMed ID: 24348752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dangers of stopping a trial too early.
    Briel M; Bassler D; Wang AT; Guyatt GH; Montori VM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():56-60. PubMed ID: 22810449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopping guidelines for an effectiveness trial: what should the protocol specify?
    Tyson JE; Pedroza C; Wallace D; D'Angio C; Bell EF; Das A
    Trials; 2016 May; 17(1):240. PubMed ID: 27165260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GRADE guidelines: 5. Rating the quality of evidence: publication bias].
    Nolting A; Perleth M; Langer G; Meerpohl JJ; Gartlehner G; Kaminski-Hartenthaler A; Schünemann HJ
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):670-6. PubMed ID: 23200211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies.
    Jitlal M; Khan I; Lee SM; Hackshaw A
    Br J Cancer; 2012 Sep; 107(6):910-7. PubMed ID: 22878376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
    Whitehead J; Matsushita T
    Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 2: Statistical considerations.
    Ball G; Piller LB
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S5-7. PubMed ID: 21664986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Bayesian randomized trials: realizing their potential.
    Pullenayegum EM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():29-33. PubMed ID: 22810444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis in randomized trials: DAMOCLES' sword?
    Besselink MG; van der Graaf Y; Gooszen HG
    J Clin Epidemiol; 2010 Apr; 63(4):353-4. PubMed ID: 19959333
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
    Shan G; Ma C; Hutson AD; Wilding GE
    J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publication bias in the anesthesiology literature.
    De Oliveira GS; Chang R; Kendall MC; Fitzgerald PC; McCarthy RJ
    Anesth Analg; 2012 May; 114(5):1042-8. PubMed ID: 22344237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.